Baseline characteristics of all CRPC patients in treatment-failure cohort.

Figshare2020-01-27 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Baseline_characteristics_of_all_CRPC_patients_in_treatment-failure_cohort_/11736090 数据链接链接失效反馈

官方服务：

资源简介：

Baseline characteristics of all CRPC patients in treatment-failure cohort.

创建时间：

2020-01-27

Systematic characterization of epigenetic modifying enzymes identifies KDM3B as a key regulator in castration resistant prostate cancer. Systematic characterization of epigenetic modifying enzymes identifies KDM3B as a key regulator in castration resistant prostate cancer

去势抵抗性前列腺癌

表观遗传靶点

Androgen deprivation therapy (ADT) is the standard care for prostate cancer patients who fail surgery and radiotherapy. While initially effective, the cancer almost always recurs into a more aggressiv

NIAID Data Ecosystem100

ARv7 represses tumor suppressors genes in castration-resistant prostate cancer [RNA-Seq]

去势抵抗性前列腺癌

转录抑制机制

Endocrine therapies in prostate cancer (PCa) treatment block androgen receptor (AR) function, but are palliative as tumors progress to a lethal, castration-resistant state (CRPC). CRPC remains depende

NIAID Data Ecosystem50

Human prostate cancer cells (VCaP and AIVCaP): siAR alone (single siRNA) vs. siAR plus OPRK1 (combo-siRNA)

去势抵抗性前列腺癌

OPRK1基因功能

Through comparative genomics using PDX models of androgen-dependent (AD) and castration-resistant (CR) tumors, we identify opioid receptor kappa 1 (OPRK1) as being associated with castration-resistanc

NIAID Data Ecosystem30

Phenotypic characterization of two novel cell line models of castration resistant prostate cancer

去势抵抗性前列腺癌

癌症耐药机制研究

Purpose: Resistance to androgen deprivation therapies is a major driver of mortality in advanced prostate cancer. Therefore, there is a need to develop new pre-clinical models that allow the investiga

NIAID Data Ecosystem50

Transcriptome profiling of castration-resistant prostate cancer cells treated with novel androgen receptor (AR) and AR-V7 inhibitors

去势抵抗性前列腺癌

雄激素受体抑制剂

The purpose of this study was to characterize the downstream transcriptomic effects of ARVib-mediated degradation of AR/AR-V7, particularly in attenuating AR/AR-V7 target gene expression in prostate c

NIAID Data Ecosystem40

Baseline characteristics of all CRPC patients in treatment-failure cohort.

资源简介：

相关数据集